Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 470

Similar articles for PubMed (Select 22773358)

1.

Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.

Neutel J, Shojaee A, Maa JF.

Adv Ther. 2012 Jun;29(6):508-23. doi: 10.1007/s12325-012-0030-z. Epub 2012 Jul 4.

PMID:
22773358
2.

Efficacy of amlodipine/olmesartan medoxomil ± HCTZ in obese patients uncontrolled on antihypertensive monotherapy.

Hsueh WA, Shojaee A, Maa JF, Neutel JM.

Curr Med Res Opin. 2012 Nov;28(11):1809-18. doi: 10.1185/03007995.2012.740632. Epub 2012 Oct 30.

PMID:
23072496
4.

A titrate-to-goal study of switching patients uncontrolled on antihypertensive monotherapy to fixed-dose combinations of amlodipine and olmesartan medoxomil ± hydrochlorothiazide.

Weir MR, Hsueh WA, Nesbitt SD, Littlejohn TJ 3rd, Graff A, Shojaee A, Waverczak WF, Qian C, Jones CJ, Neutel JM.

J Clin Hypertens (Greenwich). 2011 Jun;13(6):404-12. doi: 10.1111/j.1751-7176.2011.00437.x. Epub 2011 Feb 5.

PMID:
21649839
5.
6.

Efficacy of olmesartan medoxomil and hydrochlorothiazide fixed-dose combination therapy in patients aged 65 years and older with stage 1 and 2 hypertension or isolated systolic hypertension.

Germino FW, Neutel JM, Dubiel R, Maa JF, Chavanu KJ.

Am J Cardiovasc Drugs. 2012 Oct 1;12(5):325-33. doi: 10.2165/11635000-000000000-00000.

PMID:
22920048
7.
9.

Antihypertensive efficacy of olmesartan medoxomil or valsartan in combination with amlodipine: a review of factorial-design studies.

Ram CV.

Curr Med Res Opin. 2009 Jan;25(1):177-85. doi: 10.1185/03007990802597456 . Review.

PMID:
19210150
10.

Efficacy of amlodipine and olmesartan medoxomil in patients with hypertension: the AZOR Trial Evaluating Blood Pressure Reductions and Control (AZTEC) study.

Punzi H, Neutel JM, Kereiakes DJ, Shojaee A, Waverczak WF, Dubiel R, Maa JF.

Ther Adv Cardiovasc Dis. 2010 Aug;4(4):209-21. doi: 10.1177/1753944710374745. Epub 2010 Jun 2.

PMID:
20519261
11.

Efficacy of an amlodipine/olmesartan treatment algorithm in patients with or without type 2 diabetes and hypertension (a secondary analysis of the BP-CRUSH study).

Nesbitt SD, Shojaee A, Maa JF, Weir MR.

J Hum Hypertens. 2013 Jul;27(7):445-52. doi: 10.1038/jhh.2012.65. Epub 2012 Dec 20.

PMID:
23254596
12.

Triple-Combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in black and non-black study participants with hypertension: the TRINITY randomized, double-blind, 12-week, parallel-group study.

Chrysant SG, Littlejohn T 3rd, Izzo JL Jr, Kereiakes DJ, Oparil S, Melino M, Lee J, Fernandez V, Heyrman R.

Am J Cardiovasc Drugs. 2012 Aug 1;12(4):233-43. doi: 10.2165/11634160-000000000-00000.

PMID:
22799613
13.

Combined olmesartan, amlodipine, and hydrochlorothiazide therapy in randomized patients with hypertension: a subgroup analysis of the TRINITY study by age.

Lewin AJ, Izzo JL Jr, Melino M, Lee J, Fernandez V, Heyrman R.

Drugs Aging. 2013 Jul;30(7):549-60. doi: 10.1007/s40266-013-0072-1.

14.

Olmesartan/amlodipine/hydrochlorothiazide in participants with hypertension and diabetes, chronic kidney disease, or chronic cardiovascular disease: a subanalysis of the multicenter, randomized, double-blind, parallel-group TRINITY study.

Kereiakes DJ, Chrysant SG, Izzo JL Jr, Littlejohn T 3rd, Melino M, Lee J, Fernandez V, Heyrman R.

Cardiovasc Diabetol. 2012 Oct 30;11:134. doi: 10.1186/1475-2840-11-134.

15.

Long-term efficacy and safety of triple-combination therapy with olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide for hypertension.

Kereiakes DJ, Chrysant SG, Izzo JL Jr, Littlejohn T 3rd, Oparil S, Melino M, Lee J, Fernandez V, Heyrman R.

J Clin Hypertens (Greenwich). 2012 Mar;14(3):149-57. doi: 10.1111/j.1751-7176.2011.00588.x. Epub 2012 Jan 24.

PMID:
22372774
16.
17.
18.

Efficacy and safety of triple antihypertensive therapy with the olmesartan/amlodipine/hydrochlorothiazide combination.

Volpe M, Christian Rump L, Ammentorp B, Laeis P.

Clin Drug Investig. 2012 Oct 1;32(10):649-64. doi: 10.2165/11636320-000000000-00000.

PMID:
22909147
19.

Ambulatory blood pressure response to triple therapy with an angiotensin-receptor blocker (ARB), calcium-channel blocker (CCB), and HCTZ versus dual therapy with an ARB and HCTZ.

Duprez D, Ferdinand K, Purkayastha D, Samuel R, Wright R.

Vasc Health Risk Manag. 2011;7:701-8. doi: 10.2147/VHRM.S25743. Epub 2011 Nov 24.

20.

Efficacy and safety of olmesartan medoxomil 40 mg/hydrochlorothiazide 12.5 mg combination therapy versus olmesartan medoxomil 40 mg monotherapy in patients with moderate to severe hypertension: a randomized, double-blind, parallel-group, multicentre, multinational, phase III study.

Fogari R, Taddei S, Holm-Bentzen M, Baszak J, Melani L, Schumacher K.

Clin Drug Investig. 2010;30(9):581-97. doi: 10.2165/11536710-000000000-00000. Erratum in: Clin Drug Investig. 2013 Jan;33(1):95.

PMID:
20593911
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk